A computational approach for prioritization of patient-specific cancer drivers
Başlık çevirisi mevcut değil.
- Tez No: 652689
- Danışmanlar: PROF. DR. CESİM ERTEN, DOÇ. DR. HİLAL KAZAN
- Tez Türü: Yüksek Lisans
- Konular: Bilgisayar Mühendisliği Bilimleri-Bilgisayar ve Kontrol, Computer Engineering and Computer Science and Control
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 2020
- Dil: İngilizce
- Üniversite: Antalya Bilim Üniversitesi
- Enstitü: Lisansüstü Eğitim Enstitüsü
- Ana Bilim Dalı: Elektrik ve Bilgisayar Ana Bilim Dalı
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: 60
Özet
A major challenge in cancer genomics is to distinguish the driver mutations that are causally linked to cancer from passenger mutations that are neutral and do not contribute to cancer development. The identification of these driver genes could lead to the development of therapies. Numerous methods have been proposed for this problem; however, the majority of these methods provide a single driver gene list for the entire cohort of patients. On the other hand, mutational profiles of cancer patients show a high degree of mutational heterogeneity. As such, because the set of driver genes can be distinct for each patient, a more ideal approach is to identify patient-specific drivers. The results from such an approach can lead to the development of personalized treatments and therapies. In this thesis, we develop a computational approach that integrates genomic data, biological pathways, and protein connectivity information to identify patient-specific cancer driver genes. We construct a bipartite graph that relates specific mutated genes and various outliers for each specific patient. For each patient, we rank the mutated genes based on a convex combination of two terms. The first term is a weighted scoring of the number of connections to outlier genes of that patient as well as the outlier genes of other patients. The second term incorporates the co-occurrences of a mutated gene and an outlier gene within the same pathway. We compare our method against state-of-the-art patient-specific cancer gene prioritization methods on patients and cell line data for colon, lung, and headneck cancer. We define novel reference gene sets for evaluation of results obtained from cell line data by utilizing drug sensitivity datasets. Furthermore, we propose and discuss alternative approaches for evaluating the recovery of known cancer drivers when patient-specific drivers are provided. Overall, we show that our method can better recover known and rare cancer genes based on various reference compared to other approaches. Additionally, we demonstrate the importance of pathway coverage in the identification and ranking of driver genes.
Özet (Çeviri)
A major challenge in cancer genomics is to distinguish the driver mutations that are causally linked to cancer from passenger mutations that are neutral and do not contribute to cancer development. The identification of these driver genes could lead to the development of therapies. Numerous methods have been proposed for this problem; however, the majority of these methods provide a single driver gene list for the entire cohort of patients. On the other hand, mutational profiles of cancer patients show a high degree of mutational heterogeneity. As such, because the set of driver genes can be distinct for each patient, a more ideal approach is to identify patient-specific drivers. The results from such an approach can lead to the development of personalized treatments and therapies. In this thesis, we develop a computational approach that integrates genomic data, biological pathways, and protein connectivity information to identify patient-specific cancer driver genes. We construct a bipartite graph that relates specific mutated genes and various outliers for each specific patient. For each patient, we rank the mutated genes based on a convex combination of two terms. The first term is a weighted scoring of the number of connections to outlier genes of that patient as well as the outlier genes of other patients. The second term incorporates the co-occurrences of a mutated gene and an outlier gene within the same pathway. We compare our method against state-of-the-art patient-specific cancer gene prioritization methods on patients and cell line data for colon, lung, and headneck cancer. We define novel reference gene sets for evaluation of results obtained from cell line data by utilizing drug sensitivity datasets. Furthermore, we propose and discuss alternative approaches for evaluating the recovery of known cancer drivers when patient specific drivers are provided. Overall, we show that our method can better recover known and rare cancer genes based on various reference compared to other approaches. Additionally, we demonstrate the importance of pathway coverage in the identification and ranking of driver genes.
Benzer Tezler
- Ranking cancer drivers via betweenness-based outlier detection and random walks
Kanser sürücü genlerinin arasındalık bazlı aykırılık tanımı ve rastgele yürüyüşle tespiti
AISSA HOUDJEDJ
Yüksek Lisans
İngilizce
2021
Bilgisayar Mühendisliği Bilimleri-Bilgisayar ve KontrolAntalya Bilim ÜniversitesiElektrik ve Bilgisayar Mühendisliği Ana Bilim Dalı
PROF. DR. CESİM ERTEN
DOÇ. DR. HİLAL KAZAN
- An integrative approach to structured SNP prioritization and representative snp selection for genome-wide association studies
Genom boyutunda ilişkilendirme çalışmalarında yapılandırılmış SNP önceliklendirmesi ve temsilci snp seçimi için bütünleşik bir yaklaşım
GÜRKAN ÜSTÜNKAR
Doktora
İngilizce
2011
Bilgisayar Mühendisliği Bilimleri-Bilgisayar ve KontrolOrta Doğu Teknik ÜniversitesiBilişim Sistemleri Bölümü
PROF. DR. GERHARD WİLHELM WEBER
YRD. DOÇ. DR. YEŞİM AYDIN SON
- Yazılım tanımlı ağ tabanlı nesnelerin internetinde yönlendirme, kontrolör ve sunucu yerleştirme için mimari eniyilemesi
Architecture optimization for forwarding, controller and server placement in software defined networking enabled internet of things
YASİN İNAĞ
Doktora
Türkçe
2022
Bilgisayar Mühendisliği Bilimleri-Bilgisayar ve KontrolGazi ÜniversitesiBilgisayar Mühendisliği Ana Bilim Dalı
DOÇ. DR. MEHMET DEMİRCİ
- Development of novel tools to study atonal in Neurogenesis
Nörojenezde atonal çalışmak için yeni araçların geliştirilmesi
SVEN PIERRE L. VILAIN
Doktora
İngilizce
2009
BiyolojiKatholieke Universiteit Leuven (Catholic University of Leuven)Tıp Bilimleri Ana Bilim Dalı
PROF. DR. BASSEM HASSAN
- An optimization model to control the flow of relief commodities in humanitarian supply chain under uncertainty
Belirsiz koşullarda insani yardım tedarik zinciri malzeme akışını kontrol etmede optimizasyon modeli
ISRAA ISMAIL
Doktora
İngilizce
2021
Endüstri ve Endüstri Mühendisliğiİstanbul Teknik ÜniversitesiEndüstri Mühendisliği Ana Bilim Dalı
DOÇ. DR. ESRA BAŞ